by H.S. Ayoub
BioHealth Investor.com
Biotechnology
OSIRIS THERAPEUTICS [OSIR] +12.53%
EMERGENT BIOSOLUTION [EBS] +9.25%
ZIOPHARM ONCOLOGY IN [ZIOP] +8.91%
NANOGEN INC [NGEN] +8.20%
NEURO-HITECH INC [NHPI.OB] +6.60%
Diagnostic Substances
ADVANCE MAGNETIC [AMAG] +6.49%
REMOTEMDX INC [RMDX.OB] +6.25%
AMER BIO MEDICA [ABMC] +5.45%
AVALON PHARMACEUTIC [AVRX] +4.89%
RG GLBL LIFESTYLS [RGBL.OB] +4.20%
Drug Manufacturers
ATHEROGENICS INC [AGIX] +13.78%
RIGEL PHARMACEUTLS [RIGL] +10.94%
ISIS PHARM INC [ISIS] +6.91%
ADOLOR CORP [ADLR] +6.52%
PHARMAXIS LTD ADR [PXSL] +6.25%
Drug Related Products
AMEXDRUG CP [AXRX.OB] +7.14%
TIENS BIOTECH GR USA [TBV] +4.43%
AUXILIUM PHARMACEUT [AUXL] +4.37%
LABOPHARM INC. [DDSS] +2.95%
USANA HEALTH SCIEN [USNA] +2.80%
Generic Drugs
CATALYST PHARMACEUTI [CPRX] +4.23%
ISOLAGEN INC [ILE] +2.69%
HI-TECH PHARMACAL [HITK] +1.44%
CARACO PHARMA LABS [CPD] +1.09%
WATSON PHARMACEUTCLS [WPI] +1.07%
Medical Appliances & Equipment
SPECTRASCIENCE NEW [SCIE.OB] +13.04%
MEDICALCV INC [MCVI.OB] +10.67%
MICRUS ENDOVASCULAR [MEND] +8.44%
ENDOCARE INC [ENDO.OB] +6.80%
BSD MEDICAL CORP [BSM] +6.24%
Medical Instruments & Supplies
CARDIOTECH INTL [CTE] +9.30%
ENCISION INC [ECI] +8.03%
XTENT INC [XTNT] +5.47%
THORATEC CORP [THOR] +4.76%
LUXOTTICA GP SPA [LUX] +4.33%
Medical Laboratories & Research
SPHERIX INC [SPEX] +10.95%
PHARM PROD DEV [PPDI] +2.70%
ARRAY BIOPHARMA IN [ARRY] +2.66%
BIO-IMAGING TECH [BITI] +2.61%
OSI PHARMACEUTIC [OSIP] +2.19%
http://www.biohealthinvestor.com/
ALERT: Take This Retirement Quiz Now (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.